United Kingdom

People: AxoGen Inc (AXGN.OQ)

AXGN.OQ on NASDAQ Stock Exchange Capital Market

19 Jul 2019
Change (% chg)

$-0.72 (-3.58%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Zaderej, Karen 

Ms. Karen L. Zaderej is Chairman of the Board, President, Chief Executive Officer of the AxoGen, Inc. She has served as the CEO of AxoGen Corporation, a wholly owned subsidiary of the Company (“AC”), and a member of AC’s board of directors since May 2010. Ms. Zaderej joined AC in May 2006 and served as Vice President of Marketing and Sales from May 2006 to October 2007 and as Chief Operating Officer (“COO”) from October 2007 to May 2010. From October 2004 to May 2006, Ms. Zaderej worked for Zaderej Medical Consulting, a consulting firm she founded, which assisted medical device companies in building and executing successful commercialization plans. From 1987 to 2004, Ms. Zaderej worked at Ethicon, Inc., a Johnson & Johnson company, where she held senior positions in marketing, business development, research & development, and manufacturing. Ms. Zaderej is a Director of SEBio, a non-profit supporting the life science industry in the southeastern United States. Ms. Zaderej has an MBA from the Kellogg Graduate School of Business and a BS in Chemical Engineering from Purdue University.

Basic Compensation

Total Annual Compensation, USD 793,188
Restricted Stock Award, USD 1,903,500
Long-Term Incentive Plans, USD --
All Other, USD 1,008,280
Fiscal Year Total, USD 3,704,970

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --